Filing Details
- Accession Number:
- 0001127602-17-026088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-08-21 16:56:03
- Reporting Period:
- 2017-08-18
- Accepted Time:
- 2017-08-21 15:56:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1090872 | Agilent Technologies Inc | A | Laboratory Analytical Instruments (3826) | 770518772 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1619051 | Mark Doak | 5301 Stevens Creek Blvd Santa Clara CA 95051 | Sr. Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-08-18 | 12,421 | $40.80 | 59,498 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-08-18 | 12,421 | $61.57 | 47,077 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-08-18 | 12,421 | $0.00 | 12,421 | $40.80 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
24,842 | 2015-11-19 | 2024-11-18 | No | 4 | M | Direct |
Footnotes
- Includes 8.038 Shares acquired in the Agilent Technologies, Inc. dividend reinvestment plan
- Weighted average sale price is $61.57 with a range of $61.57-$61.58
- Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.
- The option is exercisable in four equal annual installments beginning on the first anniversary of the date of the grant. The first vesting date is stated.